Phase 2 Rheumatoid Arthritis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been treated with at least one biologic or targeted synthetic DMARD (a type of specialist arthritis medication) for 3 months or more at some point before the screening visit, and whose rheumatoid arthritis remained active during that time — or who had to stop taking it due to side effects, regardless of how long they took it. No more than 2 of these specialist medications may have been used previously.
• People who are currently taking methotrexate at a stable, unchanged dose.

Who may not be able to join:

• People who are taking anti-inflammatory pain medications (such as NSAIDs), paracetamol, certain milder opioid pain relievers (such as tramadol, codeine, or hydrocodone), oral steroid medications (at low doses equivalent to 10 mg or less of prednisone per day), or inhaled steroids for ongoing conditions — unless the dose has remained unchanged for at least 1 week before the baseline visit.
• People who have a history of any form of arthritis that began before the age of 17, or who currently have a diagnosed inflammatory joint condition other than rheumatoid arthritis.

Important: Always verify eligibility with the trial site directly before applying.